NEW YORK - Pfizer-BioNTech on Friday requested to expand the emergency use of its COVID-19 vaccine in the United States for older children ages 12 to 15. The request asks the U.S. Food and Drug ...

HOUSTON, Texas (KTRK) -- After months of waiting, Bellaire High School sophomore Nina Wallach made her first appointment for a COVID-19 vaccine Monday. "I got a notification on my phone after English ...

The US Food and Drug Administration (FDA) on Monday authorized Pfizer and BioNTech’s COVID-19 vaccine for use in adolescents 12 to 15 years of age. "The FDA's expansion of the emergency use ...

WASHINGTON — The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for young adults age 12 and older by next week, according to a federal official and a person ...

Pfizer/BioNTech has officially filed with the Food and Drug Administration seeking to expand their emergency use authorization for their COVID-19 vaccine in children aged 12 to 15 years old. When the ...

Dr. Rochelle Walensky, director of the Centers for Disease Control (CDC), endorsed a recommendation from a key advisory panel to offer Pfizer's COVID-19 booster shot to children as young as 12. "We ...

Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in ...

Pfizer said Wednesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 15, encouraging results that could clear the shots for use in middle school students before school ...

Pfizer says its COVID-19 vaccine is safe and strongly protective in kids as young as 12. The findings of Pfizer's trial, released Wednesday, showed that the vaccine recorded 100% efficacy against the ...

U.S. regulators on Monday expanded the use of Pfizer's COVID-19 vaccine to children as young as 12, offering a way to protect the nation's adolescents before they head back to school in the fall and ...

WASHINGTON — Clinical trial results of Pfizer/BioNTech's COVID-19 vaccine showed its efficacy is 100 percent and it is well tolerated in youths ages 12 to 15, the manufacturer said on Wednesday.